Hannover Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2023

  1. Practical Patient Care Considerations With Use of Vericiguat After Worsening Heart Failure Events

    Journal of Cardiac Failure, Vol. 29, Núm. 3, pp. 389-402

2022

  1. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 24, Núm. 6, pp. 927-943

2021

  1. Identification of sex-specific biomarkers predicting new-onset heart failure

    ESC Heart Failure, Vol. 8, Núm. 5, pp. 3512-3520

2020

  1. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction

    Circulation, Vol. 141, Núm. 9, pp. 751-767

2019

  1. Circulating long noncoding RNA LIPCAR Predicts heart failure outcomes in patients without chronic kidney disease

    Hypertension, Vol. 73, Núm. 4, pp. 820-828

  2. Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure: The HOMAGE Study

    Circulation: Heart Failure, Vol. 12, Núm. 5

  3. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 21, Núm. 3, pp. 272-285

2018

  1. Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

    ESC Heart Failure, Vol. 5, Núm. 1, pp. 139-148

2017

  1. Myocardial fibrosis: biomedical research from bench to bedside

    European Journal of Heart Failure, Vol. 19, Núm. 2, pp. 177-191

  2. Risk for incident heart failure: A subject-level meta-analysis from the heart "OMics" in AGEing (HOMAGE) study

    Journal of the American Heart Association, Vol. 6, Núm. 5

2015

  1. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential

    European Journal of Heart Failure, Vol. 17, Núm. 8, pp. 764-771

2002

  1. Pathophysiologic and therapeutic importance of tissue ACE: A consensus report

    Cardiovascular Drugs and Therapy, Vol. 16, Núm. 2, pp. 149-160

2001

  1. The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data

    American Journal of Cardiology, Vol. 88, Núm. 9 SUPPL. 1, pp. 1-20